共 101 条
- [1] Barone P(2002)Guidelines for the treatment of Parkinson’s disease Clin Neurol 42 430-494
- [2] Scarzella L(2006)Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease: a national multicenter parallel-group randomized study J Neurol 253 601-607
- [3] Marconi R(1978)Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness Drugs 16 273-301
- [4] Antonini A(1999)Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2 (long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells Br J Pharmacol 127 1696-1702
- [5] Morgante L(2007)Electroconvulsive therapy for neurological disorders Brain Nerve 59 313-320
- [6] Bracco F(2004)Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome Mov Disord 19 397-405
- [7] Zappia M(2000)Hallucinations in Parkinson’s disease. Prevalence, phenomenology and risk factors Brain 123 733-745
- [8] Musch B(2008)Impulse–control disorders in Parkinson’s disease CNS Spectra 13 690-698
- [9] Brogden RN(2007)Treating dopamimetic psychosis in Parkinson’s disease: structured review and meta-analysis Eur Neuropsychopharmacol 17 165-171
- [10] Heel RC(2004)Patient selection in stereotaxic neurosurgery for Parkinson’s disease: a guide to stereotactic brain operations Neurol Surg 32 1067-1075